Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-12

Clinical Trial Update: Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Anhui Province [Phase 4]

View source ↗

Summary

Phase 4 trial update on a live attenuated varicella vaccine assessing protective effect, safety, and immunogenicity in Anhui Province.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varicella vaccine, live attenuated (varicella vaccine, live attenuated)

Snippet

Sponsor: Sinovac (Dalian) Vaccine Technology Co., Ltd. | Conditions: Varicella | Phase 4 | Status: UNKNOWN